Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Genome-wide Association Studies-GWAS
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Makoto Hagiwara1, Ayako Maeda-Minami1, Fumihiro Matano2
1Faculty of Pharmaceutical Sciences, Tokyo University of Science, Japan (M.H., A.M.-M., Y. Mano).
立方体使用与下arachnoid出血 (SAH) 的风险较低有关. 这表明他类药物可能有助于预防SAH,特别是患有高血压或脑血管疾病的患者.
09:14Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: